Bristol-Myers names Bancroft as interim CFO, in lieu of Huet's departure
Pharmaceutical company Bristol-Myers Squibb has selected Charles Bancroft as its acting CFO, as its current executive vice president and CFO, Jean-Marc Huet, prepares to leave his post at the end of this year.

Effective Jan. 1, 2010, Bancroft, who previously served as vice president of the company, will report to BMS' President and COO Lamberto Andreotti.

According to the New York City-based company, Bancroft joined BMS in 1984 and has held several positions dealing with the organization's finances.